Resultaten visas 1 - 10 / 53
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Microneedles for painless transdermal immunotherapeutic applications

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jconrel.2020.12.019
Amani, Hamed; Shahbazi, Mohammad-Ali; D'Amico, Carmine; Fontana, Flavia; Abbaszadeh, Samin; Santos, ...
Journal of Controlled Release2021Publicationer information ikon

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

Referentgranskad
Öppen tillgång
DOI
10.3390/cancers15071959
Saba, Nabil F.; Pamulapati, Saagar; Patel, Bhamini; Mody, Mayur; Strojan, Primož; Takes, Robert; Mäk...
Cancers2023Publicationer information ikon

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors

Referentgranskad
Öppen tillgång
DOI
10.1158/1078-0432.CCR-18-3016
Viitala M., Virtakoivu R., Tadayon S., Rannikko J., Jalkanen S., Hollmen M.
Clinical Cancer Research2019Publicationer information ikon

A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation

Referentgranskad
Öppen tillgång
DOI
10.1016/j.mtbio.2023.100609
Abbaszadeh, Samin; Eskandari, Mohammad Reza; Nosrati-Siahmazgi, Vahideh; Musaie, Kiyan; Mehrabi, Sor...
Materials today bio2023Publicationer information ikon

The case for plant-made veterinary immunotherapeutics

Referentgranskad
DOI
10.1016/j.biotechadv.2016.02.007
Topp, Edward; Irwin, Rebecca; McAllister, Tim; Lessard, Martin; Joensuu, Jussi J.; Kolotilin, Igor; ...
Biotechnology Advances2016Publicationer information ikon

Enhanced passive safety surveillance of standard-dose and high-dose influenza vaccines in Finland and Germany 2023-24 season

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2025.2475616
Machado, Marina Amaral de Avila; Gallo, Sophie; Goldstein, Alexander; Vachhani, Parth; Byrareddy, Re...
Human vaccines & immunotherapeutics2025Publicationer information ikon

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2023.2278940
Yang, Tae Un; Vargas-Zambrano, Juan C.; Park, Hang A.; Jung, Chae Won; Kim, Dongwook; Jee, Youngmee
Human Vaccines & Immunotherapeutics2023Publicationer information ikon

Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone:Results from a randomized, phase 2a, non-inferiority trial

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2023.2187194
Galgani, Ilaria; Poder, Airi; Jogi, Rain; Anttila, Veli-Jukka; Milleri, Stefano; Borobia, Alberto M....
Human vaccines & immunotherapeutics2023Publicationer information ikon

Influenza vaccination uptake and its determinants during the 2019-2020 and early 2020-2021 flu seasons among migrants in Shanghai, China: a cross-sectional survey

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2021.2016006
Han, Kaiyi; Han, Kaiyi; Francis, Mark R.; Xia, Aichen; Zhang, Ruiyun; Hou, Zhiyuan
HUMAN VACCINES & IMMUNOTHERAPEUTICS2022Publicationer information ikon

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2021.1902701
Piazza, Franco M.;Virta, Miia;Paassilta, Marita;Paassilta, Marita;Ukkonen, Benita;Ahonen, Anitta;Est...
human vaccines immunotherapeutics2021

Microneedles for painless transdermal immunotherapeutic applications

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jconrel.2020.12.019
2021

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

Referentgranskad
Öppen tillgång
DOI
10.3390/cancers15071959
2023

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors

Referentgranskad
Öppen tillgång
DOI
10.1158/1078-0432.CCR-18-3016
2019

A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation

Referentgranskad
Öppen tillgång
DOI
10.1016/j.mtbio.2023.100609
2023

The case for plant-made veterinary immunotherapeutics

Referentgranskad
DOI
10.1016/j.biotechadv.2016.02.007
2016

Enhanced passive safety surveillance of standard-dose and high-dose influenza vaccines in Finland and Germany 2023-24 season

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2025.2475616
2025

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2023.2278940
2023

Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone:Results from a randomized, phase 2a, non-inferiority trial

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2023.2187194
2023

Influenza vaccination uptake and its determinants during the 2019-2020 and early 2020-2021 flu seasons among migrants in Shanghai, China: a cross-sectional survey

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2021.2016006
2022

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2021.1902701
2021